BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24436062)

  • 1. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.
    Konerman MA; Mehta SH; Sutcliffe CG; Vu T; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS
    Hepatology; 2014 Mar; 59(3):767-75. PubMed ID: 24436062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.
    Pace FH; Ferreira LE; Silva AE; Ferraz ML
    Rev Soc Bras Med Trop; 2012; 45(4):444-7. PubMed ID: 22930041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.
    Leite AG; Duarte MI; Mendes-Correa MC
    J Int Assoc Provid AIDS Care; 2015; 14(5):463-8. PubMed ID: 26056147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
    AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.
    Macías J; Berenguer J; Japón MA; Girón JA; Rivero A; López-Cortés LF; Moreno A; González-Serrano M; Iribarren JA; Ortega E; Miralles P; Mira JA; Pineda JA
    Hepatology; 2009 Oct; 50(4):1056-63. PubMed ID: 19670415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.
    Macías J; Berenguer J; Japón MA; Girón-González JA; Rivero A; López-Cortés LF; Moreno A; Márquez M; Iribarren JA; Ortega E; Miralles P; Merchante N; Pineda JA
    Hepatology; 2012 Oct; 56(4):1261-70. PubMed ID: 22508322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
    J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.
    Kliemann DA; Wolff FH; Tovo CV; Alencastro PR; Ikeda ML; Brandão AB; Barcellos N; Fuchs SC
    Ann Hepatol; 2016; 15(1):27-32. PubMed ID: 26626637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
    Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
    Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients.
    Sagnelli C; Uberti-Foppa C; Galli L; Pasquale G; Coppola N; Albarello L; Doglioni C; Lazzarin A; Sagnelli E
    Braz J Infect Dis; 2014; 18(2):164-9. PubMed ID: 24650995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.
    Woreta TA; Sutcliffe CG; Mehta SH; Brown TT; Higgins Y; Thomas DL; Torbenson MS; Moore RD; Sulkowski MS
    Gastroenterology; 2011 Mar; 140(3):809-17. PubMed ID: 21134375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.
    Mohsen AH; Easterbrook PJ; Taylor C; Portmann B; Kulasegaram R; Murad S; Wiselka M; Norris S
    Gut; 2003 Jul; 52(7):1035-40. PubMed ID: 12801963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
    Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
    AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
    Sterling RK; Lissen E; Clumeck N; Sola R; Correa MC; Montaner J; S Sulkowski M; Torriani FJ; Dieterich DT; Thomas DL; Messinger D; Nelson M;
    Hepatology; 2006 Jun; 43(6):1317-25. PubMed ID: 16729309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.
    Ryder SD; Irving WL; Jones DA; Neal KR; Underwood JC;
    Gut; 2004 Mar; 53(3):451-5. PubMed ID: 14960533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus.
    Guzmán-Fulgencio M; Berenguer J; García-Álvarez M; Fernández-Rodríguez A; Jiménez-Sousa MA; Alvarez E; Micheloud D; López JC; Miralles P; Cosín J; Catalán P; Resino S
    J Infect; 2013 Feb; 66(2):170-8. PubMed ID: 23103287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of liver fibrosis in monoinfected patients by hepatitis C virus and coinfected by HCV and human immunodeficiency virus.
    Tovo CV; Becker SC; Almeida PR; Galperim B; Chaves S
    Arq Gastroenterol; 2013; 50(1):19-22. PubMed ID: 23657302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
    Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
    Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.